# A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

> **NCT00696800** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1509 (actual)

## Conditions studied

- In Vitro Fertilization

## Interventions

- **DRUG:** Corifollitropin alfa
- **BIOLOGICAL:** RecFSH / Follitropin beta (Days 1 to 7)
- **DRUG:** Placebo Corifollitropin alfa
- **DRUG:** Placebo RecFSH / follitropin beta
- **BIOLOGICAL:** RecFSH / Follitropin beta (Days 8 to hCG)
- **DRUG:** Ganirelix
- **BIOLOGICAL:** hCG
- **BIOLOGICAL:** Progesterone

## Key facts

- **NCT ID:** NCT00696800
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06-27
- **Primary completion:** 2007-11-19
- **Final completion:** 2008-01-15
- **Target enrollment:** 1509 (ACTUAL)
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696800, "A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00696800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*